The First Case of an Infant with Familial A20 Haploinsufficiency in Korea

被引:12
|
作者
Kim, Hye-Young [1 ]
Song, Ji Yeon [2 ]
Kim, Woo-Il [3 ]
Ko, Hyun-Chang [3 ]
Park, Su Eun [2 ]
Jang, Ja-Hyun [4 ]
Kim, Seong Heon [2 ,5 ]
机构
[1] Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Pediat,Sch Med, Busan, South Korea
[2] Pusan Natl Univ, Dept Pediat, Childrens Hosp, 20 Geumo Ro, Yangsan 50612, South Korea
[3] Pusan Natl Univ, Dept Dermatol, Yangsan Hosp, Yangsan, South Korea
[4] Green Cross Genome, Lab Med, Yongin, South Korea
[5] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea
关键词
Haploinsufficiency A20; Familial Behcet Disease; Neonatal Lupus Erythematosus; Infant;
D O I
10.3346/jkms.2020.35.e252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haploinsufficiency of A20 (HA20) is a newly described autoinflammatory disease caused by loss-of-function mutations in the TNFAIP3 gene. Clinical phenotypes are heterogenous and resemble Behcet's disease, juvenile idiopathic arthritis, inflammatory bowel disease, or periodic fever syndrome, with symptoms developing at an early age. Here, we report the first case of infantile familial HA20 in Korea, which mimics neonatal lupus erythematosus (NLE). A 2-month-old infant exhibited symptoms including recurrent fever, erythematous rashes, and oral ulcers, with elevated liver enzymes, and tested positive for several autoantibodies, similar to systemic lupus erythematosus (SLE); therefore, she was suspected to have NLE. However, six months after birth, symptoms and autoantibodies persisted. Then, we considered the possibility of other diseases that could cause early onset rashes and abnormal autoantibodies, including autoinflammatory syndrome, monogenic SLE, or complement deficiency, all of which are rare. The detailed family history revealed that her father had recurrent symptoms, including oral and genital ulcers, knee arthralgia, abdominal pain, and diarrhea. These Behcet-like symptoms last for many years since he was a teenager, and he takes medications irregularly only when those are severe, but doesn't want the full-scale treatment. Whole-exome sequencing was conducted to identify a possible genetic disorder, which manifested as pathogenic variant nonsense mutation in the TNFAIP3 gene, leading to HA20. In conclusion, HA20 should be considered in the differential diagnosis of an infant with an early-onset dominantly inherited inflammatory disease that presents with recurrent oral and genital ulcerations and fluctuating autoantibodies. Additionally, it also should be considered in an infant with suspected NLE, whose symptoms and abnormal autoantibodies persist.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Clinical characteristics and genetic analysis of A20 haploinsufficiency
    Zhang, Dan
    Su, Gaixiu
    Zhou, Zhixuan
    Lai, Jianming
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [22] Chronic hepatic involvement in the clinical spectrum of A20 haploinsufficiency
    Deshayes, Samuel
    Bazille, Celine
    El Khouri, Elma
    Kone-Paut, Isabelle
    Giurgea, Irina
    Georgin-Lavialle, Sophie
    Silva, Nicolas Martin
    Dumont, Anael
    Ollivier, Isabelle
    Amselem, Serge
    de Boysson, Hubert
    Aouba, Achille
    LIVER INTERNATIONAL, 2021, 41 (08) : 1894 - 1900
  • [23] Hematopoietic Cell Transplantation Ameliorates Autoinflammation in A20 Haploinsufficiency
    Mayuka Shiraki
    Eleri Williams
    Norifumi Yokoyama
    Kunihiro Shinoda
    Zohreh Nademi
    Kana Matsumoto
    Hiroshi Nihira
    Yoshitaka Honda
    Kazushi Izawa
    Ryuta Nishikomori
    Mary A. Slatter
    Andrew J. Cant
    Andrew R. Gennery
    Hidenori Ohnishi
    Hirokazu Kanegane
    Journal of Clinical Immunology, 2021, 41 : 1954 - 1956
  • [24] Hematopoietic Cell Transplantation Ameliorates Autoinflammation in A20 Haploinsufficiency
    Shiraki, Mayuka
    Williams, Eleri
    Yokoyama, Norifumi
    Shinoda, Kunihiro
    Nademi, Zohreh
    Matsumoto, Kana
    Nihira, Hiroshi
    Honda, Yoshitaka
    Izawa, Kazushi
    Nishikomori, Ryuta
    Slatter, Mary A.
    Cant, Andrew J.
    Gennery, Andrew R.
    Ohnishi, Hidenori
    Kanegane, Hirokazu
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (08) : 1954 - 1956
  • [25] Interferon Signature Predicts Response to Tofacitinib in Haploinsufficiency of A20
    Blackstone, Sarah
    Schwartz, Daniella
    Moura, Natalia Sampaio
    Stone, Deborah
    Waldman, Meryl
    Hoffmann, Patrycja
    Jones, Anne
    Romeo, Tina
    Barron, Karyl
    Milner, Joshua
    Kastner, Daniel
    Ombrello, Amanda
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [26] A20 haploinsufficiency: what do clinicians need to know?
    Elhani, I.
    Aouba, A.
    Riller, Q.
    Vergneault, H.
    Boursier, G.
    Rieux-Laucat, F.
    Hentgen, V.
    Georgin-Lavialle, S.
    REVUE DE MEDECINE INTERNE, 2024, 45 (07): : 415 - 422
  • [27] Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment
    Mei-Ping Yu
    Xi-Sheng Xu
    Qing Zhou
    Natalie Deuitch
    Mei-Ping Lu
    World Journal of Pediatrics, 2020, 16 : 575 - 584
  • [28] Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement
    Aeschlimann, Florence A.
    Laxer, Ronald M.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 506 - 513
  • [29] A Novel Variant in TNFAIP3 Causes A20 Haploinsufficiency
    Rosenberg, Daniel
    CLINICAL IMMUNOLOGY, 2024, 262
  • [30] Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment
    Yu, Mei-Ping
    Xu, Xi-Sheng
    Zhou, Qing
    Deuitch, Natalie
    Lu, Mei-Ping
    WORLD JOURNAL OF PEDIATRICS, 2020, 16 (06) : 575 - 584